Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
LUXA was delisted on the 28th of October, 2022.
57 hedge funds and large institutions have $228M invested in Lux Health Tech Acquisition Corp. Class A Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.
704% more call options, than puts
Call options by funds: $6.34M | Put options by funds: $789K
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
14% more capital invested
Capital invested by funds: $200M → $228M (+$28.2M)
8.81% more ownership
Funds ownership: 58.61% → 67.42% (+8.8%)
4% more funds holding
Funds holding: 55 → 57 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$9.19M |
| 2 |
RIA
RP Investment Advisors
Toronto,
Ontario, Canada
|
+$8.22M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$6.19M |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
+$5.91M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$5.16M |
| 2 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
-$3.95M |
| 3 |
SI
Symmetry Investments
St Helier,
Jersey
|
-$1.74M |
| 4 |
Goldman Sachs
New York
|
-$1.16M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$858K |
LUXA Hedge Fund Activity: Q3 2021 in Review
57 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q3 2021, worth a combined $228M — up 14% from $200M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LUXA positions and 6 closed out — a net gain of 2 holders — while 18 added to existing stakes and 10 trimmed.
The largest buyer was Weiss Asset Management, adding an estimated $9.19M. The largest seller was Manulife (Manufacturers Life Insurance), exiting entirely with an estimated $5.16M sold.
- 57 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q3 2021, up from 55 in Q2 2021.
- Funds reported $228M of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q3 2021, up 14% quarter-over-quarter.
- 8 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q3 2021 and 6 closed out, a net change of +2 holders.
- The largest Lux Health Tech Acquisition Corp. Class A Common Stock buyer in Q3 2021 was Weiss Asset Management, an estimated $9.19M added.
- The largest Lux Health Tech Acquisition Corp. Class A Common Stock seller in Q3 2021 was Manulife (Manufacturers Life Insurance), an estimated $5.16M sold.
Based on aggregated 13F filings for Q3 2021.